Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial

Havel, L., Zemanová, M., Pešek, M., Kolek, V., Spíšek, R., Bartůňková, J., Pecen, L., Krasnopolskaya, I., Černovská, M. Dendritic-cell vaccine (DCVAC) with first line chemotherapy in patients with stage IV NSCLC primary analysis of phase 2, open-label, randomized, multicenter trial. Journal of Clinical Oncology. 2018, 36(15 suppl), 9051-9051. ISSN 0732-183X. E-ISSN 1527-7755. Available: doi: 10.1200/JCO.2018.36.15_suppl.9051